Adherence in tamoxifen therapy after conversion to a rebate pharmaceutical in breast cancer patients in Germany.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International journal of clinical pharmacology and therapeutics

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5414/CP201969PMID 24120719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adherence to adjuvant endocrine therapy in women with breast cancer

  2013cited by this paper
• Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis

  2013cited by this paper
• Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?

  2012cited by this paper
• Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study

  2012cited by this paper
• Medical Record Databases

  2012cited by this paper
• Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review

  2012cited by this paper
• Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer

  2011cited by this paper
• Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy.

  2010cited by this paper
• [Drug therapy in primary care in the light of discount contracts to health insurers--a patient survey].

  2010cited by this paper
• Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer

  2010cited by this paper
• Estimates of cancer incidence and mortality in Europe in 2008.

  2010cited by this paper
• [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].

  2009cited by this paper
• Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies.

  2009cited by this paper
• Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.

  2008cited by this paper
• Medizinische Probleme und Risiken bei der rabattvertragsgerechten Umstellung von Inhalatoren in Deutschland

  2008cited by this paper
• [More and more discount contracts. A chance to be free of the budget pressure].

  2007cited by this paper
• Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.

  2006cited by this paper
• Therapietreue bei medikamentöser Behandlung

  2006cited by this paper
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

  2005cited by this paper
• A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases.

  2003cited by this paper
• Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.

  2003cited by this paper
• Patient compliance with antibiotic treatment for respiratory tract infections.

  2002cited by this paper

• Hidden Costs of Endocrine Therapy for Black Breast Cancer Survivors: A Qualitative Examination of Patient and Provider Experiences.

  2025cites this paper
• Treatment-related side effects among Hispanic and non-Hispanic white long-term breast cancer survivors by tamoxifen use and duration

  2023cites this paper
• The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review

  2022influential citation
• Intersektorale Versorgung – Best Practices am Beispiel Brustkrebs

  2020cites this paper
• A systematic review of interventions to improve adherence to endocrine therapy

  2018influential citation
• Prospective systemic risk analysis of the dispensing process in German community pharmacies

  2018cites this paper
• Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review

  2017cites this paper
• Reimbursement changes and drug switching: are severe patients more affected?

  2017cites this paper
• More than just side-effects: The role of clinical and psychosocial factors in non-adherence to tamoxifen.

  2017cites this paper
• Understanding tamoxifen adherence in women with breast cancer: A qualitative study.

  2017cites this paper
• More than just side effects: the role of clinical and psychosocial factors in non-adherence to tamoxifen

  2017cites this paper
• More than just side effects: the role of clinical and psychosocial factors in non-adherence to tamoxifen

  2017cites this paper
• Reference Pricing for Generics: Unplanned Consequences of Planned Swiss Regulation

  2016cites this paper
• Poor persistence with hormonal therapy among women with breast cancer.

  2016cites this paper
• Putting evidence into practice: evidence-based interventions for oral agents for cancer.

  2015cites this paper
• Adherence to Adjuvant Endocrine Therapy for Breast Cancer: Importance in Women with Low Income

  2015cites this paper
• Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research

  2014influential citation